Projected Income Statement: UACJ Corporation

Forecast Balance Sheet: UACJ Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 325,113 341,870 270,468 323,224 330,273 377,202 381,812 365,271
Change - 5.15% -20.89% 19.51% 2.18% 14.21% 1.22% -4.33%
Announcement Date 12/05/22 11/05/23 13/05/24 13/05/25 14/05/26 - - -
1JPY in Million
Estimates

Cash Flow Forecast: UACJ Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 20,728 26,394 33,181 37,504 55,677 56,243 53,664 54,953
Change - 27.34% 25.71% 13.03% 48.46% 1.02% -4.58% 2.4%
Free Cash Flow (FCF) 1 -13,236 25,659 58,700 -27,754 4,498 -22,850 38,200 37,600
Change - 293.86% 128.77% -147.28% 116.21% -608% 267.18% -1.57%
Announcement Date 12/05/22 11/05/23 13/05/24 13/05/25 14/05/26 - - -
1JPY in Million
Estimates

Forecast Financial Ratios: UACJ Corporation

Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 11.51% 5.66% 8.94% 9.56% 9.9% 9.38% 9.21% 8.21%
EBIT Margin (%) 7.6% 1.79% 3.51% 5.74% 6.5% 6.4% 5.71% 5.82%
EBT Margin (%) 6.4% 0.74% 2.46% 4.31% 5.39% 5.48% 4.61% 4.76%
Net margin (%) 4.09% 0.49% 1.55% 2.8% 3.29% 3.24% 2.77% 2.86%
FCF margin (%) -1.69% 2.66% 6.57% -2.78% 0.38% -1.67% 2.77% 2.71%
FCF / Net Income (%) -41.29% 545.59% 423.58% -99.2% 11.57% -51.61% 100% 94.72%

Profitability

        
ROA 6.7% 1.03% 2.48% 4.57% 6.09% 4.2% - 2%
ROE 15.6% 2% 5.3% 9.9% 12.2% 12.97% 9.75% 9.49%

Financial Health

        
Leverage (Debt/EBITDA) 3.61x 6.27x 3.39x 3.38x 2.82x 2.94x 3.01x 3.21x
Debt / Free cash flow -24.56x 13.32x 4.61x -11.65x 73.43x -16.51x 10x 9.71x

Capital Intensity

        
CAPEX / Current Assets (%) 2.65% 2.74% 3.72% 3.75% 4.71% 4.11% 3.89% 3.96%
CAPEX / EBITDA (%) 23% 48.43% 41.58% 39.27% 47.61% 43.84% 42.26% 48.22%
CAPEX / FCF (%) -156.6% 102.86% 56.53% -135.13% 1,237.82% -246.14% 140.48% 146.15%

Items per share

        
Cash flow per share 1 324.7 198 260.6 346.2 436.1 - - -
Change - -39.02% 31.6% 32.86% 25.97% - - -
Dividend per Share 1 21.25 21.25 22.5 37.5 55 59 64 65.6
Change - 0% 5.88% 66.67% 46.67% 7.27% 8.47% 2.5%
Book Value Per Share 1 1,182 1,286 1,436 1,605 1,916 2,112 2,216 2,349
Change - 8.79% 11.7% 11.77% 19.37% 10.21% 4.93% 5.98%
EPS 1 166.2 24.38 71.84 146.5 214.8 239.3 232.1 219.3
Change - -85.33% 194.63% 103.9% 46.59% 11.43% -3.02% -5.51%
Nbr of stocks (in thousands) 192,893 192,887 192,880 181,035 181,069 181,069 181,069 181,069
Announcement Date 12/05/22 11/05/23 13/05/24 13/05/25 14/05/26 - - -
1JPY
Estimates
2027 *2028 *
P/E 9.48x 9.77x
PBR 1.07x 1.02x
EV / Sales 0.58x 0.57x
Yield 2.6% 2.82%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
2,268.00JPY
Average target price
3,201.67JPY
Spread / Average Target
+41.17%

Quarterly revenue - Rate of surprise